Allergy and Immunology · Grand Rapids, MI
NPI
1326333444
Since 2011
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3271 Clear Vista Ct NE
Grand Rapids, MI, 49525
Phone (616) 267-7125
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,037
98 services
Medicare patients, 2024
24
Average age 71
Drug cost, 2024
$2.8M
397 prescriptions
Company payments, 2025
$176K
From 22 companies
Medicare prescription drug claims, 2024
In 2024, the drug Theodore E Kelbel prescribed most often to Medicare patients was Ipratropium Bromide, with 57 prescriptions and refills. In total Theodore E Kelbel wrote 397 Medicare prescriptions that cost $2.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ipratropium Bromide Generic | 57 | 78 | 18 | $1,957 |
| Montelukast Sodium Generic | 56 | 104 | 12 | $635 |
| Takhzyro Lanadelumab-Flyo | 38 | 38 | Under 11 | $1.7M |
| Famotidine Generic | 28 | 44 | Under 11 | $408 |
| Azelastine Hcl Generic | 25 | 50 | 13 | $719 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 23 | 23 | Under 11 | $14K |
| Spiriva Respimat Tiotropium Bromide | 18 | 19 | Under 11 | $9,251 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 17 | 19 | Under 11 | $637 |
| Fluticasone Propionate Generic | 14 | 32 | Under 11 | $244 |
| Icatibant Icatibant Acetate | 14 | 14 | Under 11 | $269K |
| Hydroxyzine Hcl Generic | 11 | 21 | Under 11 | $176 |
| Prednisone Generic | 11 | 11 | Under 11 | $18.6 |
Brand drugs: 140 claims; generic drugs: 257 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Theodore E Kelbel $176K ($176K in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $45K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 64 | $45K |
| Genentech USA, Inc. ROG.SW | 41 | $28K |
| Ionis Pharmaceuticals, Inc. IONS | 29 | $23K |
| Pharming Healthcare, Inc. | 31 | $14K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 18 | $12K |
| GlaxoSmithKline, LLC. GSK | 19 | $11K |
| Genzyme Corporation SNY | 11 | $9,683 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 17 | $8,351 |
| CSL Behring CSL.AX | 12 | $6,932 |
| BioCryst Pharmaceuticals, Inc. BCRX | 10 | $6,492 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.